{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:54:41Z","timestamp":1775156081630,"version":"3.50.1"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this report is to assess the efficacy and adverse event profile of photon-based stereotactic radiosurgery (SRS) compared with fractionated stereotactic radiotherapy (fSRT) for the treatment of uveal melanoma. Primary outcomes include incidence proportions of local control, enucleation, metastatic progression, disease-specific, and overall mortality. Treatment-related toxicities such as incidence proportions of radiation retinopathy, neovascular glaucoma, optic neuropathy, and cataract formation were examined as secondary outcomes. Five-year survival and 5-year local control rates were also assessed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and Methods:<\/jats:title>\n            <jats:p>PubMed, Embase, Web of Science, Scopus, and 2 Cochrane databases were searched up to December 31, 2018. Random effects models were used to calculate pooled incidence proportions of outcome measures. Meta-regression was carried out to explore the potential impact of dose per fraction on local control.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Twenty-four articles with a total of 1745 patients were included in the meta-analysis. There were no statistically significant differences between photon-based fSRT and SRS for all primary, secondary and 5-year outcome measures, including local control (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.28), enucleation (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.51), and neovascular glaucoma (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.40). The 5-year local control rate was 90% (95% confidence interval: 76%, 96%) for fSRT and 89% (70%, 97%) for SRS.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Our meta-analysis showed no difference in tumor control, survival and toxicities, as defined in this paper, between SRS and fSRT for uveal melanoma. Confounding biases remain an expected limitation in this study of novel treatment modalities deployed in rare tumors. Further investigation is needed to validate outcomes and compare stereotactic treatment techniques.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/coc.0000000000000775","type":"journal-article","created":{"date-parts":[[2020,11,20]],"date-time":"2020-11-20T23:08:51Z","timestamp":1605913731000},"page":"32-42","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":22,"title":["Systematic Review and Meta-Analysis on the Use of Photon-based Stereotactic Radiosurgery Versus Fractionated Stereotactic Radiotherapy for the Treatment of Uveal Melanoma"],"prefix":"10.1097","volume":"44","author":[{"given":"Samuel","family":"Kosydar","sequence":"first","affiliation":[{"name":"University of Washington School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jake C.","family":"Robertson","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Woodfin","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina A.","family":"Mayr","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"},{"name":"Department of Radiation Oncology, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arjun","family":"Sahgal","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Sunnybrook Health Science Centre, Toronto, ON, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Timmerman","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon S.","family":"Lo","sequence":"additional","affiliation":[{"name":"University of Washington School of Medicine"},{"name":"Department of Radiation Oncology, University of Washington, Seattle, WA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,11,17]]},"reference":[{"key":"R1-20250527","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ctrv.2012.01.002","article-title":"Uveal melanoma","volume":"38","author":"Spagnolo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"R2-20250527","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archophthalmol.2009.208","article-title":"Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes","volume":"127","author":"Shields","year":"2009","journal-title":"Arch Ophthalmol"},{"key":"R3-20250527","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0039-6257(88)90173-7","article-title":"Epidemiologic aspects of uveal melanoma","volume":"32","author":"Egan","year":"1988","journal-title":"Surv Ophthalmol"},{"key":"R4-20250527","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/01.iio.0000195852.08453.de","article-title":"Metastatic uveal melanoma therapy current options","volume":"46","author":"Bedikian","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R5-20250527","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1097\/IAE.0000000000002144","article-title":"Large uveal melanoma (>= 10 mm thickness) clinical features and millimeter-by-millimeter risk of metastasis in 1311 cases. The 2018 Albert E. Finley Lecture","volume":"38","author":"Shields","year":"2018","journal-title":"Retina"},{"key":"R6-20250527","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jamaophthalmol.2015.4810","article-title":"Hepatic ultrasonography for surveillance in patients with uveal melanoma","volume":"134","author":"Choudhary","year":"2016","journal-title":"JAMA Opthalmol"},{"key":"R7-20250527","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1755-3768.1982.tb08371.x","article-title":"Malignant melanomas of the human uvea: 25-year follow-up of cases in Denmark, 1943-1952","volume":"60","author":"Jensen","year":"1982","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R8-20250527","first-page":"1","article-title":"Uveal melanoma in Finland. An epidemiological, clinical, histological and prognostic study","volume":"33","author":"Raivio","year":"1977","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"R9-20250527","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ophtha.2011.01.040","article-title":"Uveal melanoma: trends in incidence, treatment, and survival","volume":"118","author":"Singh","year":"2011","journal-title":"Ophthalmology"},{"key":"R10-20250527","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0360-3016(03)00006-3","article-title":"The American Brachytherapy Society recommendations for brachytherapy of uveal melanomas","volume":"56","author":"Nag","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R11-20250527","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/eye.2012.249","article-title":"Effects of radiotherapy on uveal melanomas and adjacent tissues","volume":"27","author":"Groenewald","year":"2013","journal-title":"Eye"},{"key":"R12-20250527","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/archopht.119.7.969","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: Initial mortality findings: COMS report no. 18","volume":"119","author":"Diener-West","year":"2001","journal-title":"Arch Ophthalmol"},{"key":"R13-20250527","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00066-009-1900-4","article-title":"The effectiveness and safety of proton radiation therapy for indications of the eye","volume":"185","author":"Bekkering","year":"2009","journal-title":"Strahlenther Onkol"},{"key":"R14-20250527","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijrobp.2012.08.026","article-title":"Charged particle radiation therapy for uveal melanoma: a systematic review and meta-analysis","volume":"86","author":"Wang","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R15-20250527","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/153303460600500409","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiotherapy in the treatment of uveal melanoma","volume":"5","author":"Henderson","year":"2006","journal-title":"Technol Cancer Res Treat"},{"key":"R16-20250527","first-page":"44","article-title":"Stereotactic body radiation therapy: a novel treatment modality","volume":"7","author":"Lo","year":"2009","journal-title":"Nature"},{"key":"R17-20250527","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/neuonc\/nou284","article-title":"The biology of radiosurgery and its clinical applications for brain tumors","volume":"17","author":"Kondziolka","year":"2015","journal-title":"Neuro Oncol"},{"key":"R18-20250527","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9394(14)72665-0","article-title":"Single-dose compared with fractionated-dose radiation of the OM431 choroidal melanoma cell line","volume":"120","author":"Logani","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R19-20250527","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1016\/S0161-6420(00)00151-2","article-title":"Stereotactic radiosurgery of large uveal melanomas with the gamma-knife\u2014discussion","volume":"107","author":"Gragoudas","year":"2000","journal-title":"Opthalmology"},{"key":"R20-20250527","doi-asserted-by":"crossref","first-page":"640","DOI":"10.3171\/jns.2002.97.supplement_5.0640","article-title":"High-compared with low-dose radiosurgery for uveal melanomas","volume":"97","author":"Langmann","year":"2002","journal-title":"J Neurosurg"},{"key":"R21-20250527","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00701-017-3164-6","article-title":"Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review","volume":"159","author":"Persson","year":"2017","journal-title":"Acta Neurochir (Wien)"},{"key":"R22-20250527","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.jns.2016.11.024","article-title":"Safety and efficacy of fractionated stereotactic radiotherapy and stereotactic radiosurgery for treatment of pituitary adenomas: a systematic review and meta-analysis","volume":"372","author":"Li","year":"2017","journal-title":"J Neurol Sci"},{"key":"R23-20250527","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"R24-20250527","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R25-20250527","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1136\/jech-2013-203104","article-title":"Meta-analysis of prevalence","volume":"67","author":"Barendregt","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"R27-20250527","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"R28-20250527","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jrsm.1240","article-title":"Power analysis for random-effects meta-analysis","volume":"8","author":"Jackson","year":"2017","journal-title":"Res Synth Methods"},{"key":"R30-20250527","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13014-018-1088-9","article-title":"Linear accelerator-based stereotactic fractionated photon radiotherapy as an eye-conserving treatment for uveal melanoma","volume":"13","author":"Akbaba","year":"2018","journal-title":"Radiat Oncol"},{"key":"R31-20250527","doi-asserted-by":"crossref","first-page":"E455","DOI":"10.1016\/j.ijrobp.2011.05.012","article-title":"Stereotactic fractionated radiotherapy in the treatment of juxtapapillary choroidal melanoma: the McGill University Experience","volume":"81","author":"Al-Wassia","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-20250527","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s00701-011-1252-6","article-title":"Survival and complications following Gamma Knife radiosurgery or enucleation for ocular melanoma: a 20-year experience","volume":"154","author":"Dinca","year":"2012","journal-title":"Acta Neurochir (Wien)"},{"key":"R33-20250527","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ijrobp.2010.04.035","article-title":"Local tumor control, visual acuity, and survival after hypofractioned stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"81","author":"Dunavoelgyi","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R34-20250527","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ijrobp.2011.06.1957","article-title":"Radiogenic side effects after hypofractionated stereotactic photon radiotherapy of choroidal melanoma in 212 patients treated between 1997 and 2007","volume":"83","author":"Dunavoelgyi","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R35-20250527","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CMR.0000000000000199","article-title":"Robotic radiosurgery for the treatment of medium and large uveal melanoma","volume":"26","author":"Eibl-Lindner","year":"2016","journal-title":"Melanoma Res"},{"key":"R36-20250527","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000098525","article-title":"Gamma-Knife-based stereotactic radiosurgery for uveal melanoma","volume":"85","author":"Fakiris","year":"2007","journal-title":"Stereotact Funct Neurosurg"},{"key":"R37-20250527","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4149\/neo_2018_171209N808","article-title":"Uveal melanoma survival rates after single dose stereotactic radiosurgery","volume":"65","author":"Furdova","year":"2018","journal-title":"Neoplasma"},{"key":"R38-20250527","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1136\/bjophthalmol-2017-310801","article-title":"Predictors of radio-induced visual impairment after radiosurgery for uveal melanoma","volume":"102","author":"Gigliotti","year":"2018","journal-title":"Br J Opthalmol"},{"key":"R39-20250527","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3928\/23258160-20140306-05","article-title":"Local control and results of leksell gamma knife therapy for the treatment of uveal melanoma","volume":"45","author":"Joye","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"suppl","key":"R40-20250527","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3171\/2012.8.GKS121002","article-title":"Long-term results of Gamma Knife surgery for uveal melanomas","volume":"117","author":"Kang","year":"2012","journal-title":"J Neurosurg"},{"key":"R41-20250527","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000099812","article-title":"Gamma Knife stereotactic radiosurgery for uveal melanoma: clinical results after 2 years","volume":"66","author":"Marchini","year":"1996","journal-title":"Stereotact Funct Neurosurg"},{"key":"R42-20250527","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/bjo.2008.142208","article-title":"Gamma knife radiosurgery for uveal melanoma: 12 years of experience","volume":"93","author":"Modorati","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"R43-20250527","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/S0161-6420(00)00150-0","article-title":"Stereotactic radiosurgery of large uveal melanomas with the gamma-knife","volume":"107","author":"Mueller","year":"2000","journal-title":"Ophthalmology"},{"key":"R44-20250527","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.radonc.2011.06.038","article-title":"Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results","volume":"102","author":"Muller","year":"2012","journal-title":"Radiother Oncol"},{"key":"R45-20250527","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00417-012-2144-z","article-title":"Gamma-knife-based stereotactic radiosurgery for medium- and large-sized posterior uveal melanoma","volume":"251","author":"Sarici","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R46-20250527","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3171\/jns.2002.97.supplement_5.0635","article-title":"Leksell gamma knife treatment of uveal melanoma","volume":"97","author":"Simonova","year":"2002","journal-title":"J Neurosurg"},{"key":"R47-20250527","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40942-017-0070-2","article-title":"Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases","volume":"3","author":"Reynolds","year":"2017","journal-title":"Int J Retina Vitreous"},{"key":"R48-20250527","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3129\/i08-177","article-title":"Stereotactic radiotherapy in the treatment of juxtapapillary choroidal melanoma: 2-year follow-up","volume":"44","author":"Somani","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"R49-20250527","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1001\/jamaophthalmol.2013.697","article-title":"Retrospective evaluation of patients with uveal melanoma treated by stereotactic radiosurgery with and without tumor resection","volume":"131","author":"Suesskind","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"R50-20250527","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jocn.2009.08.004","article-title":"Gamma knife stereotactic radiosurgery yields good long-term outcomes for low-volume uveal melanomas without intraocular complications","volume":"17","author":"Toktas","year":"2010","journal-title":"J Clin Neurosci"},{"key":"R51-20250527","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/bjophthalmol-2012-302399","article-title":"Visual acuity after Gamma-Knife radiosurgery of choroidal melanomas","volume":"97","author":"Wackernagel","year":"2013","journal-title":"Br J Opthalmol"},{"key":"R52-20250527","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1136\/bjophthalmol-2013-304031","article-title":"Local tumour control and eye preservation after gamma-knife radiosurgery of choroidal melanomas","volume":"98","author":"Wackernagel","year":"2014","journal-title":"Br J Opthalmol"},{"key":"R53-20250527","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2017.02.017","article-title":"Stereotactic radiosurgery and fractionated stereotactic radiation therapy for the treatment of uveal melanoma","volume":"98","author":"Yazici","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R54-20250527","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0167-8140(00)00164-X","article-title":"Local tumor control and morbidity after one to three fractions of stereotactic external beam irradiation for uveal melanoma","volume":"55","author":"Zehetmayer","year":"2000","journal-title":"Radiother Oncol"},{"key":"R55-20250527","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0161-6420(02)01277-0","article-title":"The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19","volume":"109","author":"Jampol","year":"2002","journal-title":"Ophthalmology"},{"key":"R56-20250527","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ophtha.2008.10.013","article-title":"I-125 brachytherapy for choroidal melanoma: photographic & angiographic abnormalities. Collaborative ocular melanoma study: COMS report no. 30","volume":"116","author":"Boldt","year":"2009","journal-title":"Ophthalmology"},{"key":"R57-20250527","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"},{"key":"R58-20250527","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000455872","article-title":"Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose","volume":"3","author":"Echegaray","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"R59-20250527","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13311-014-0276-z","article-title":"Gamma knife for functional diseases","volume":"11","author":"R\u00e9gis","year":"2014","journal-title":"Neurotherapeutics"},{"key":"R60-20250527","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1365-2265.2004.02138.x","article-title":"Radiosurgery for pituitary adenomas","volume":"61","author":"Brada","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"R61-20250527","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1748-717X-6-158","article-title":"Frameless linac-based stereotactic radiosurgery (SRS) for brain metastases: analysis of patient repositioning using a mask fixation system and clinical outcomes","volume":"6","author":"Minniti","year":"2011","journal-title":"Radiat Oncol"},{"key":"R62-20250527","first-page":"55","article-title":"Local control and overall survival after frameless radiosurgery: a single center experience","volume":"7","author":"Bilger","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"R63-20250527","first-page":"1","article-title":"Frameless image-guided radiosurgery for trigeminal neuralgia","volume":"8","author":"Shields","year":"2017","journal-title":"Surg Neurol Int"},{"key":"R64-20250527","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1198\/000313001300339897","article-title":"The abuse of power","volume":"55","author":"Hoenig","year":"2001","journal-title":"Am Stat"},{"key":"R65-20250527","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.ijrobp.2018.10.038","article-title":"Single versus multifraction stereotactic radiosurgery for large brain metastases: an international meta-analysis of 24 trials radiation oncology","volume":"103","author":"Lehrer","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R66-20250527","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2014.12.041","article-title":"Ataxia telangiectasiae mutated gene polymorphisms and acute normal tissue injuries in cancer patients after radiation therapy: a systematic review and meta-analysis","volume":"91","author":"Dong","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T17:08:08Z","timestamp":1748365688000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,17]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000775","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,17]]}}}